These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 23054708)

  • 41. Haemoglobin degradation underpins the sensitivity of early ring stage Plasmodium falciparum to artemisinins.
    Xie SC; Dogovski C; Hanssen E; Chiu F; Yang T; Crespo MP; Stafford C; Batinovic S; Teguh S; Charman S; Klonis N; Tilley L
    J Cell Sci; 2016 Jan; 129(2):406-16. PubMed ID: 26675237
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Structure-based design, synthesis and evaluation of conformationally constrained cysteine protease inhibitors.
    Scheidt KA; Roush WR; McKerrow JH; Selzer PM; Hansell E; Rosenthal PJ
    Bioorg Med Chem; 1998 Dec; 6(12):2477-94. PubMed ID: 9925304
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Falcipain Inhibitors Based on the Natural Product Gallinamide A Are Potent in Vitro and in Vivo Antimalarials.
    Stoye A; Juillard A; Tang AH; Legac J; Gut J; White KL; Charman SA; Rosenthal PJ; Grau GER; Hunt NH; Payne RJ
    J Med Chem; 2019 Jun; 62(11):5562-5578. PubMed ID: 31062592
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of novel falcipain-2 inhibitors as potential antimalarial agents through structure-based virtual screening.
    Li H; Huang J; Chen L; Liu X; Chen T; Zhu J; Lu W; Shen X; Li J; Hilgenfeld R; Jiang H
    J Med Chem; 2009 Aug; 52(15):4936-40. PubMed ID: 19586036
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Discovery of new antimalarial agents: Second-generation dual inhibitors against FP-2 and PfDHFR via fragments assembely.
    Chen W; Huang Z; Wang W; Mao F; Guan L; Tang Y; Jiang H; Li J; Huang J; Jiang L; Zhu J
    Bioorg Med Chem; 2017 Dec; 25(24):6467-6478. PubMed ID: 29111368
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Computation-based virtual screening for designing novel antimalarial drugs by targeting falcipain-III: a structure-based drug designing approach.
    Kesharwani RK; Singh DV; Misra K
    J Vector Borne Dis; 2013; 50(2):93-102. PubMed ID: 23995310
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Crystal structures of reversible ketone-Based inhibitors of the cysteine protease cruzain.
    Huang L; Brinen LS; Ellman JA
    Bioorg Med Chem; 2003 Jan; 11(1):21-9. PubMed ID: 12467703
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparative molecular field analysis and molecular docking studies on novel aryl chalcone derivatives against an important drug target cysteine protease in Plasmodium falciparum.
    Thillainayagam M; Anbarasu A; Ramaiah S
    J Theor Biol; 2016 Aug; 403():110-128. PubMed ID: 27185536
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Design and synthesis of novel 2-pyridone peptidomimetic falcipain 2/3 inhibitors.
    Verissimo E; Berry N; Gibbons P; Cristiano ML; Rosenthal PJ; Gut J; Ward SA; O'Neill PM
    Bioorg Med Chem Lett; 2008 Jul; 18(14):4210-4. PubMed ID: 18554905
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Michael acceptor based antiplasmodial and antitrypanosomal cysteine protease inhibitors with unusual amino acids.
    Breuning A; Degel B; Schulz F; Büchold C; Stempka M; Machon U; Heppner S; Gelhaus C; Leippe M; Leyh M; Kisker C; Rath J; Stich A; Gut J; Rosenthal PJ; Schmuck C; Schirmeister T
    J Med Chem; 2010 Mar; 53(5):1951-63. PubMed ID: 20131843
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of antimalarial leads with dual falcipain-2 and falcipain-3 inhibitory activity.
    Rana D; Kalamuddin M; Sundriyal S; Jaiswal V; Sharma G; Das Sarma K; Sijwali PS; Mohmmed A; Malhotra P; Mahindroo N
    Bioorg Med Chem; 2020 Jan; 28(1):115155. PubMed ID: 31744777
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Structural features of falcipain-3 inhibitors: an in silico study.
    Wang J; Li F; Li Y; Yang Y; Zhang S; Yang L
    Mol Biosyst; 2013 Sep; 9(9):2296-310. PubMed ID: 23765034
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A small-molecule inhibitor of the DNA recombinase Rad51 from
    Vydyam P; Dutta D; Sutram N; Bhattacharyya S; Bhattacharyya MK
    J Biol Chem; 2019 May; 294(20):8171-8183. PubMed ID: 30936202
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Selection of cysteine protease inhibitor-resistant malaria parasites is accompanied by amplification of falcipain genes and alteration in inhibitor transport.
    Singh A; Rosenthal PJ
    J Biol Chem; 2004 Aug; 279(34):35236-41. PubMed ID: 15192087
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tetraoxane-pyrimidine nitrile hybrids as dual stage antimalarials.
    Oliveira R; Guedes RC; Meireles P; Albuquerque IS; Gonçalves LM; Pires E; Bronze MR; Gut J; Rosenthal PJ; Prudêncio M; Moreira R; O'Neill PM; Lopes F
    J Med Chem; 2014 Jun; 57(11):4916-23. PubMed ID: 24824551
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Designing novel inhibitors against falcipain-2 of Plasmodium falciparum.
    Himangini ; Pathak DP; Sharma V; Kumar S
    Bioorg Med Chem Lett; 2018 May; 28(9):1566-1569. PubMed ID: 29602682
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis and in vitro evaluation of gold(I) thiosemicarbazone complexes for antimalarial activity.
    Khanye SD; Smith GS; Lategan C; Smith PJ; Gut J; Rosenthal PJ; Chibale K
    J Inorg Biochem; 2010 Oct; 104(10):1079-83. PubMed ID: 20621360
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Profiling the structural determinants of heteroarylnitrile scaffold-based derivatives as falcipain-2 inhibitors by in silico methods.
    Wang J; Li Y; Yang Y; Zhang S; Yang L
    Curr Med Chem; 2013; 20(15):2032-42. PubMed ID: 23410155
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular interaction of artemisinin with translationally controlled tumor protein (TCTP) of Plasmodium falciparum.
    Eichhorn T; Winter D; Büchele B; Dirdjaja N; Frank M; Lehmann WD; Mertens R; Krauth-Siegel RL; Simmet T; Granzin J; Efferth T
    Biochem Pharmacol; 2013 Jan; 85(1):38-45. PubMed ID: 23085438
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differences in biochemical properties of the Plasmodial falcipain-2 and berghepain-2 orthologues: implications for in vivo screens of inhibitors.
    Chan C; Goh LL; Sim TS
    FEMS Microbiol Lett; 2005 Aug; 249(2):315-21. PubMed ID: 16019160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.